[e-drug] Prescrire's response to EU Commission's consultation on Paediatric Regulation

e-drug
1

E-DRUG: Prescrire's response to EU Commission's consultation on Paediatric Regulation
----------------------------------------------------------------------------------------------------------

The 10-year experience gained with the Paediatric Regulation has shown the limitations and/or abuses of a reward/incentive system aimed at stimulating R&D in areas of major medical need. It clearly illustrates that the pharmaceutical industry "plays the system" to obtain the highest possible financial rewards.

- Prescrire invites the European and national public authorities to invest more in public or academically-driven clinical research focused on real health needs, including paediatric medicines.

- Click here to download Prescrire's response (pdf, 95 Ko) <http://english.prescrire.org/Docu/DOCSEUROPE/20190219_PrescrireResponseEUPaediatricRegulation.pdf&gt;

Rita KESSLER
European Advocacy Officer
www.prescrire.org <http://www.prescrire.org/&gt;
rkessler@prescrire.org